Classical IL‐1a/IL‐1B signaling through the IL‐1R1 complex as described in Figure 2 (A). IL‐1Ra is a natural competitive inhibitor that competes with the IL‐1 ligand at the receptor site (B). Once it binds to the receptor, there is no ensuing downstream activation, because IL‐1Ra lacks the domain that allows it to bind to the IL‐1R AcP. Binding between IL‐1 and IL‐1R2 does not initiate the activation pathway (C). IL‐1R2 molecules are decoy receptors; once they bind to IL‐1 they form a trimeric complex with IL‐1R AcP, separate from the cells and exist in a soluble state (sIL‐1R2). It is believed that by binding to IL‐1R2, IL‐1 is kept away from its signaling receptor (IL‐1R1). sIL‐1R2 can also bind to the pro‐form of IL‐1 (pro‐IL‐1) and possibly other forms, preventing cleavage by extracellular proteases. IL‐1β indicates interleukin‐1 beta; IL‐1R1, interleukin‐1 receptor type‐I; IL‐1R AcP, IL‐1 receptor accessory protein; IL‐1Ra, interleukin‐1 receptor antagonist; IRAK1/4, interleukin‐1 receptor‐associated kinase 1/4; MyD88, myeloid differentiation primary response protein 88; and sIL‐1R2, soluble interleukin‐1 receptor type‐2